ImmuPharma plc Positive on 2008 Progress

May 12, 2008 |

1 min read

LONDON (Thomson Financial) - ImmuPharma Plc. posted a bullish update alongside its 2007 results, saying it expects to report further progress in 2008, principally the results of its Phase IIb trial for its key drug candidate for lupus.

Earnings Europe

MORE ON THIS TOPIC

Podcast

CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP

July 2, 2025

·

1 min read

·

Heather McKenzie

A contemporary artistic collage depicting a hand holding pills, passing them to another hand. The concept of medication and treatment.

Collaboration

Argenx Makes $1.5B+ Play for UNP’s Macrocyclic Peptides Aimed at ‘Undruggable’ Targets

July 1, 2025

·

2 min read

·

Tristan Manalac

Contemporary art collage, female palms in the orange circle, a bag of money. Concept of business and finance.

Mergers & acquisitions

AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies

June 30, 2025

·

2 min read

·

Dan Samorodnitsky

Illustration showing businessman bringing personal items in box stock

Layoffs

BMS Continues New Jersey Layoffs, Bringing Yearly Total to Nearly 900

June 30, 2025

·

1 min read

·